Soleno Therapeutics Announces Publication of Results from Previously Completed Phase II Trial of DCCR for Treatment of Prader-Willi Syndrome
Stock Information for Soleno Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.